Pfizer Inc. recalled Bicillin L-A injectable suspension distributed nationwide on July 10, 2025, due to current good manufacturing practice deviations that allowed particulates to enter the product, according to the FDA.
How to tell if you have it
- Brand: Pfizer
- Product: Bicillin L-A (penicllin G benzathine injectable suspension)
- Strength/Size: 1,200,000 units per 2 mL, 2 mL-vial
- Carton NDC: 60793-701-10
- Syringe NDC: 60793-701-02
- Lot codes: HJ3235 (Exp 09/30/26), GL2954, HP6222 (Exp 01/31/27), HR9967 (Exp 05/31/27), HP6232, LT5190 (Exp 09/30/27), HP6228 (Exp 10/31/27)
- Units affected: 50,855 vials
- Distribution: Nationwide in the USA
The hazard
The recall addresses current good manufacturing practice deviations where particulates were identified during visual inspection of the injectable suspension.
Context
GovInfoNow's records show Pfizer Inc. has issued 71 other recalls since November 26, 2012. Recent Pfizer recalls include a August 4, 2025 epinephrine vial recall for sterility risks, a May 28, 2025 dobutamine injection recall for discoloration, and a May 20, 2024 labetalol injection recall for incomplete crimp seals. Other recent recalls of similar products include a January 2, 2026 Cipla Lanreotide Injection recall, an August 12, 2026 B. Braun Medical Lactated Ringer's Injection recall, and a March 24, 2026 GE Healthcare Omnipaque 300 mg/mL Injection recall.